To test the hypothesis that SNAIL cooperates specifically with KRAS, but not WNT pathway activation, to induce cancer progression across tumour entities, we activated SNAIL in vivo in a KRASG12D-driven model of serrated intestinal cancer (Fig. 2g). The gene discussed is KRAS; the disease is intestinal cancer.